Researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically ...

Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes in patients with ulcerative colitis ...

Upadacitinib may offer superior disease management than tofacitinib for patients with ulcerative colitis. Learn more.

A simple, non-invasive treatment focused on the ears could one day provide relief for people with ulcerative colitis, a UM ...

Inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis, affects millions of ...

Topline Clinical Data Demonstrates Activity of SOR102 Across Multiple Clinical Endpoints Supporting Advancement to Phase 2 ...

Discover how β-ionone offers relief from ulcerative colitis by enhancing gut health, reducing inflammation, and restoring ...

An appendectomy may help improve or prevent symptoms in people with ulcerative colitis. However, evidence on this topic is mixed, and more research is needed. Ulcerative colitis (UC) is a type of ...

anti-IL-7 Receptor Lusvertikimab in Ulcerative Colitis accepted for Oral Presentation and selected amongst the Top 10 oral ...

Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...

The top gastroenterology biosimilar news from 2024 highlight fluctuations in the adalimumab biosimilar market throughout the ...

Understanding current trends in the incidence, prevalence, and distribution of ulcerative colitis can help inform diagnosis and treatment.